Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal.
Vial
J H
JH
Department of Medicine, University of Tasmania, Australia.
McLeod
L J
LJ
Roberts
M S
MS
D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine*; D000328:Adult; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D008297:Male; D011897:Random Allocation; D013927:Thrombosis / Q000209:etiology; D013929:Thromboxane B2 / Q000652:urine*; D013997:Time Factors
D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D001241:Aspirin